REGENEREX PHARMA, INC. Selling, General and Administrative Expense
REGENEREX PHARMA, INC. reported Selling, General and Administrative Expense of $1.16 million for the 12-month period ending 2025-03-31, per its 10-K filed 2025-06-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2025-06-30
- REGENEREX PHARMA, INC. selling, general and administrative expense for fiscal 2025 was $1.16M, a 9.18% increase from fiscal 2024.
- REGENEREX PHARMA, INC. selling, general and administrative expense for fiscal 2024 was $1.07M.
| Period end | Selling, General and Administrative Expense 12 month |
|---|---|
| 2025-03-31 | $1.16M 10-K · filed 2025-06-30 |
| 2024-03-31 | $1.07M 10-K · filed 2025-06-30 |